Metabolys Overview
- Year Founded
-
2008
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
Metabolys General Information
Description
Operator of a clinical research firm intended to predict the safety and efficacy of test compounds. The company's services specialize in developing cellular metabolomics and antidiabetic medication for evaluating brain metabolism and the effects of new treatments for neurodegenerative diseases, thereby helping researchers with the selection and development of compound tests.
Contact Information
Website
www.metabolys.comCorporate Office
- 181 avenue Jean Jaurès
- 69007 Lyon
- France
Corporate Office
- 181 avenue Jean Jaurès
- 69007 Lyon
- France
Metabolys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Out of Business | 01-Jan-2023 | Completed | Out of Business | |||
| 8. Later Stage VC | 01-Jan-2017 | Completed | Clinical Trials - General | |||
| 7. Grant | 01-Jan-2015 | Completed | Clinical Trials - General | |||
| 6. Angel (individual) | 01-Jan-2014 | Completed | Startup | |||
| 5. Grant | 01-Jul-2010 | Completed | Startup | |||
| 4. Angel (individual) | 01-Jan-2010 | Completed | Startup | |||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2008 | Completed | Pre-Clinical Trials |
Metabolys Comparisons
Industry
Financing
Details
Metabolys Competitors (5)
One of Metabolys’s 5 competitors is Poxel, a Formerly VC-backed company based in Lyon, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Poxel | Formerly VC-backed | Lyon, France | ||||
| ENYO Pharma | Venture Capital-Backed | Lyon, France | ||||
| Novo Nordisk | Corporation | Bagsvaerd, Denmark | ||||
| Pfizer | Corporation | New York, NY | ||||
| Madrigal Participaciones | Corporate Backed or Acquired | Valladolid, Spain |
Metabolys Patents
Metabolys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2017307341-A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | Inactive | 04-Aug-2016 | ||
| CA-3032607-A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | Inactive | 04-Aug-2016 | ||
| EP-3278802-A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | Inactive | 04-Aug-2016 | ||
| EP-3493806-A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | Pending | 04-Aug-2016 | ||
| US-20190160057-A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | Active | 04-Aug-2016 | A61K31/496 |
Metabolys Signals
Metabolys FAQs
-
When was Metabolys founded?
Metabolys was founded in 2008.
-
Where is Metabolys headquartered?
Metabolys is headquartered in Lyon, France.
-
What is the size of Metabolys?
Metabolys has 7 total employees.
-
What industry is Metabolys in?
Metabolys’s primary industry is Drug Discovery.
-
Is Metabolys a private or public company?
Metabolys is a Private company.
-
What is Metabolys’s current revenue?
The current revenue for Metabolys is .
-
How much funding has Metabolys raised over time?
Metabolys has raised $1.29M.
-
Who are Metabolys’s competitors?
Poxel, ENYO Pharma, Novo Nordisk, Pfizer, and Madrigal Participaciones are competitors of Metabolys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process